Status:
COMPLETED
Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass
Lead Sponsor:
Yale University
Conditions:
Congenital Heart Defects
Eligibility:
All Genders
Up to 18 years
Brief Summary
During cardiopulmonary bypass (CPB) after heart surgery, a child's blood is exposed to many foreign entities. These conditions trigger the body's inflammatory response which results in leaky capillari...
Detailed Description
During cardiopulmonary bypass (CPB) for corrective or palliative congenital heart surgery, a child's blood is subjected to hemodilution, hypothermia, nonpulsatile blood flow and exposure to foreign an...
Eligibility Criteria
Inclusion
- Pediatric patients with congenital heart disease undergoing surgical intervention requiring cardiopulmonary bypass and modified ultrafiltration.
Exclusion
- Any patients with congenital heart disease who will not require modified ultrafiltration.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01489475
Start Date
November 1 2011
End Date
June 1 2013
Last Update
February 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Children's Hospital
New Haven, Connecticut, United States, 06520